Viewing Study NCT07219420


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:20 AM
Study NCT ID: NCT07219420
Status: RECRUITING
Last Update Posted: 2025-12-03
First Post: 2025-10-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Sponsor: UCB Biopharma SRL
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-11-14
Start Date Type: ACTUAL
Primary Completion Date: 2027-12-27
Primary Completion Date Type: ESTIMATED
Completion Date: 2029-10-29
Completion Date Type: ESTIMATED
First Submit Date: 2025-10-17
First Submit QC Date: None
Study First Post Date: 2025-10-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-12-02
Last Update Post Date: 2025-12-03
Last Update Post Date Type: ESTIMATED